Results 111 to 120 of about 4,568 (194)

A phase 3 randomized study evaluating sialic acid extended-release for GNE myopathy [PDF]

, 2019
Hanns Lochmüller, Anthony Béhin, Yoseph Caraco, Heather Lau, Massimiliano Mirabella, Ivailo Tournev, Mark A. Tarnopolsky, Oksana Pogoryelova, C. G. Woods, Alexander C. Lai, Jinay Shah, Tony Koutsoukos, Alison Skrinar, Hank Mansbach, Emil Kakkis, Tahseen Mozaffar   +15 more
openalex   +1 more source

847. Safety and Toxicity Profile of Intra-Muscular and Systemic Delivery of a Novel GNE DNA Liposomal Nanoparticle (GDLP) for Gene Therapy of Hereditary Inclusion Body Myopathy (HIBM2) [PDF]

, 2008

openalex   +1 more source

Quantitative analysis of inhibitor-induced assembly disruption in human UDP-GlcNAc 2-epimerase using mass photometry. [PDF]

Protein Sci
Boback N, López JG, Hackenberger CPR, Di Lella S, Lauster DC.   +4 more
europepmc   +1 more source

Funktionelle Bedeutung der UDP-N-Acetylglukosamin 2-Epimerase/N -Acetylmannosamin-Kinase (GNE) für die Anoikis von Tumorzellen

, 2010
Pia Kessel
openalex   +2 more sources

Neural architecture search using network embedding and generative adversarial networks. [PDF]

Sci Rep
Yousefi M, Mehrdad V, Dowlatshahi MB.
europepmc   +1 more source

Muscle MRI Contributes to the Differential Diagnosis Between Distal Myopathies and Distal Hereditary Motor Neuropathies. [PDF]

Eur J Neurol
Payá M, Portela S, Sivera R, Frasquet M, Más-Estellés F, Martí P, Azorín I, Aragon-Gawinska K, Tárrega M, Argente-Escrig H, Vázquez-Costa JF, Vilchez R, Vilchez JJ, Sevilla T, Muelas N.   +14 more
europepmc   +1 more source

586. A Single Patient, Multiple Intravenous (IV) Infusion, Clinical Trial of GNE-Lipoplex for Therapy of Hereditary Inclusion Body Myopathy (HIBM) [PDF]

, 2010

openalex   +1 more source

Assessment of Lectin Staining Biomarkers using a Murine Model of GNE Myopathy. [PDF]

MicroPubl Biol
Parker O, Woods J, Rothkopf M, Drach D, Wetzel HN, Crowe KE.   +5 more
europepmc   +1 more source

Polybromo‑1 Bromodomain Inhibitor Selectivity Is Mediated by a Unique Ligand-Binding Pocket. [PDF]

ACS Med Chem Lett
Nuñez R, Bursch KL, Makowski SJ, Xue M, Cozzolino KA, Shishodia S, Keyes RF, Zhu N, Smith BC.   +8 more
europepmc   +1 more source

ManNAc attenuates Man5 glycoform abundance through GNE-mediated metabolic channeling of UDP-GlcNAc to N-glycosylation modifications via CMP-Neu5Ac biosynthesis. [PDF]

MAbs
Sun R, Chai M, Man J, Yang G, Shu H, Wang Q, Tian C, Wang L, Liao S, Zhang Y, Cao Y, Xia L, Yang H, Zhang T, Ma L, Cao S, Gao Q, Le Y, Shi M, Li Q, Fan Y, Zhou H.   +21 more
europepmc   +1 more source